IceCure Medical Ltd. Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ICCM Company Description
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
ICCM Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ICCM Smart Score
Score Breakdown
ICCM Company Description
Show More
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ICCM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ICCM's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ICCM in WallStreetBets Daily Discussion
ICCM News
Recent insights relating to ICCM
CNBC Recommendations
Recent picks made for ICCM stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ICCM
Corporate Flights
Flights by private jets registered to ICCM
Our Analysis